Ardelyx (ARDX) revenue breakdown
By product, IBSRELA is the largest at 67% of fiscal 2025 revenue; XPHOZAH grew fastest, 548% a year over 2 years.
By region, United States is the largest at 93% of fiscal 2025 revenue, growing 189% a year over 3 years.
Revenue by product
Fiscal years, as Ardelyx reports them in its 10-K filings; fiscal 2025 total $407M.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| IBSRELA | — | — | — | — | — | $80M | $158M | $274M | 67% |
| XPHOZAH | — | — | — | — | — | $2M | $161M | $104M | 25% |
| Product supply revenue | $287,000 | $322,000 | $2M | $907,000 | $2M | $6M | $12M | $16M | 4% |
| Non-cash royalty revenue related to the sale of future royalties | — | — | — | — | — | — | $3M | $9M | 2% |
| Licensing revenue | $2M | $4M | $706,000 | $5M | $35M | $36M | $78,000 | $5M | 1% |
| Product sales, net | — | — | — | — | $16M | — | — | — | — |
| Collaborative development revenue | — | $459,000 | $5M | — | — | — | — | — | — |
| Collaborative development revenue | — | — | — | $4M | — | — | — | — | — |
Revenue by region
Fiscal years, as Ardelyx reports them in its 10-K filings; fiscal 2025 total $407M.
| Regions | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| United States | — | — | — | — | $16M | $83M | $319M | $378M | 93% |
| Asia Pacific | — | $287,000 | $7M | $10M | $31,000 | $41M | $14M | $29M | 7% |
| North America | — | $2M | $806,000 | $13,000 | $37M | $59,000 | $78,000 | $342,000 | 0% |
| Japan | $30M | — | — | — | — | — | — | — | — |
| China | $12M | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ARDX.
Open ARDX in InvestinglyQuestions
Where does Ardelyx make its money?
In fiscal 2025, by product: IBSRELA $274M, XPHOZAH $104M, Product supply revenue $16M, Non-cash royalty revenue related to the sale of future royalties $9M, Licensing revenue $5M.
From Ardelyx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.